NMDA receptor hypofunction model of schizophrenia
- 29 November 1999
- journal article
- review article
- Published by Elsevier
- Vol. 33 (6) , 523-533
- https://doi.org/10.1016/s0022-3956(99)00029-1
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Disseminated Corticolimbic Neuronal Degeneration Induced in Rat Brain by MK-801: Potential Relevance to Alzheimer's DiseaseNeurobiology of Disease, 1998
- Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkeyJournal of Comparative Neurology, 1998
- Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist NeurotoxicityNeuropsychopharmacology, 1998
- Safety and Tolerability of the Glutamate Antagonist CGS 19755 (Selfotel) in Patients With Acute Ischemic StrokeStroke, 1995
- Competitive and noncompetitive NMDA antagonists induce similar limbic degenerationNeuroReport, 1994
- MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysisNeuroscience Letters, 1993
- NMDA Antagonist Neurotoxicity: Mechanism and PreventionScience, 1991
- Ketamine: an update on the first twenty-five years of clinical experienceCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1989
- Ketamine‐lorazepamAnaesthesia, 1978
- Effect of thiopentone on emergence reactions to ketamine anaesthesiaCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1974